Clinical Trial Update: A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS)

View source ↗

Summary

Clinical update on the OCTOPUS trial evaluating treatment for patients with BRAF V600E-mutant metastatic non-small cell lung cancer; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Metastatic Non-small Cell Lung Cancer, BRAF V600 Mutation | Status: COMPLETED